November 16, 2015.
Ernst & Young have named Jean-Jacques Bienaimé, CEO of BioMarin Pharmaceutical, as EY Entrepreneur Of The Year 2015 in the Life Sciences category.
The award recognizes entrepreneurs "who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities". Jean-Jacques Bienaimé was selected by an independent panel of judges and honored at the EY Entrepreneur Of The Year National Awards gala on November 14, 2015, in Palm Springs, California.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.